Vivani Medical Toekomstige groei

Future criteriumcontroles 0/6

Vivani Medical's winst zal naar verwachting dalen met 10.3% per jaar. De winst per aandeel zal naar verwachting dalen met 5.8% per jaar.

Belangrijke informatie

-10.3%

Groei van de winst

-5.8%

Groei van de winst per aandeel

Medical Equipment winstgroei	17.1%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	13 Nov 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Companies Like Vivani Medical (NASDAQ:VANI) Are In A Position To Invest In Growth

Apr 07

We Think Vivani Medical (NASDAQ:VANI) Can Afford To Drive Business Growth

Dec 06

Winst- en omzetgroeiprognoses

NasdaqCM:VANI - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	N/A	-32	N/A	N/A	1
12/31/2025	N/A	-26	N/A	-22	2
12/31/2024	N/A	-24	N/A	-19	2
9/30/2024	N/A	-23	-19	-18	N/A
6/30/2024	N/A	-24	-22	-20	N/A
3/31/2024	N/A	-25	-22	-21	N/A
12/31/2023	N/A	-26	-25	-24	N/A
9/30/2023	N/A	-27	-26	-25	N/A
6/30/2023	N/A	-19	-25	-25	N/A
3/31/2023	N/A	-16	-23	-23	N/A
12/31/2022	N/A	-14	-19	-19	N/A
9/30/2022	N/A	-10	-17	-17	N/A
6/30/2022	N/A	-15	-13	-13	N/A
3/31/2022	N/A	-14	-12	-12	N/A
12/31/2021	N/A	-13	-12	-11	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat VANI de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat VANI de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat VANI de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van VANI naar verwachting sneller zal groeien dan de markt US.

Hoge groei-inkomsten: Er wordt verwacht dat VANI volgend jaar geen omzet zal hebben.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van VANI naar verwachting over 3 jaar hoog zal zijn

Vivani Medical Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical, Inc. Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

We Think Vivani Medical (NASDAQ:VANI) Needs To Drive Business Growth Carefully

Vivani Medical, Inc. Provides Update on Clinical Development Plans for Miniature, Long-Term, GLP-1 Obesity Implant Program, NPM-115

Vivani Medical, Inc. Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Vivani Medical, Inc. Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Vivani Medical, Inc., Annual General Meeting, Jun 27, 2024

Vivani Medical, Inc. has filed a Follow-on Equity Offering in the amount of $75 million.

New minor risk - Market cap size

Director notifies of intention to sell stock

New major risk - Revenue and earnings growth

Vivani Medical, Inc. Appoints Daniel Bradbury to Its Board of Directors

Vivani Medical, Inc. has filed a Follow-on Equity Offering in the amount of $15 million.

New major risk - Share price stability

Vivani Medical, Inc. Receives Written Notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC Regarding Minimum Bid Price Requirement

Vivani Medical, Inc. Receives Written Notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC Regarding Minimum Bid Price Requirement

Independent Chairman of the Board recently bought US$135k worth of stock

Is Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth?

New major risk - Financial position

Independent Chairman of the Board recently bought US$103k worth of stock

Independent Chairman of the Board recently bought US$90k worth of stock

Independent Chairman of the Board recently bought US$97k worth of stock

Independent Chairman of the Board recently bought US$50k worth of stock

Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation

Director recently bought US$1.8m worth of stock

Companies Like Vivani Medical (NASDAQ:VANI) Are In A Position To Invest In Growth

We Think Vivani Medical (NASDAQ:VANI) Can Afford To Drive Business Growth

No independent directors

Vivani Medical, Inc.(NasdaqCM:VANI) dropped from S&P Global BMI Index

Vivani Medical, Inc. Announces Chief Executive Officer Changes

No independent directors

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven